US FDA extends review of KalVista's swelling disorder drug due to heavy workload

reuters.com/business/healthcare-pharmaceuticals/us-fda-extends-review-kalvistas-swelling-disorder-drug-due-heavy-workload-2025-06-13

This story appeared on reuters.com, 2025-06-13 20:41:34.372000.
The Entire Business World on a Single Page. Free to Use →